Sep 13 |
XORTX Announces Results of Annual and Special Meeting of Shareholders
|
Sep 12 |
XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A
|
Sep 6 |
XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders
|
Sep 3 |
Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders
|
Aug 30 |
Why MongoDB Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
|
Aug 29 |
Dow Jumps Over 100 Points; Nvidia Earnings Top Views
|
Aug 29 |
XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism
|
Aug 23 |
XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders
|
Aug 20 |
XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024
|
Jun 4 |
XORTX to Present at BIO International Convention 2024
|